logo
Why climbing the stairs can be good for your body and brain

Why climbing the stairs can be good for your body and brain

BBC News30-05-2025
While it is tempting to take the lift or escalator rather than use the stairs, even scaling just a few flights a day could give your health and mind a boost.
As expeditions go, it was a gruelling one. In just under 23 hours on 3 September 2021, Sean Greasley climbed and descended 8,849 m (29,032ft) – a distance that would have taken him to the top of the highest mountain on Earth. By the end, he was dripping in sweat and could barely walk. And he did it all in the relative comfort of his own home.
Greasley holds the world record for the fastest time to ascend and descend the same height as Mount Everest on stairs, achieving it in 22 hours, 57 minutes and two seconds.
While Greasley achieved this on the staircase at his home in Las Vegas, there are others who take stair climbing to other extremes. Tower running, for example, involves racing up enormous flights of stairs inside iconic buildings and skyscrapers. There is even a Tower Running Association and an official tower running global ranking for the elite athletes dedicated to this unusual sport.
Most of us are unlikely to achieve such giddy heights, yet even climbing a few flights of stairs in our daily lives might be something to aspire to. According to research, climbing stairs can have surprising benefits for both your physical health and your brain without needing to hurtle up two steps at a time or break records.
Climbing stairs has been found to improve balance and reduce the risk of falling for older people and improve their lower body strength. Other studies also find that climbing a couple of flights of stairs can positively affect our cognitive abilities such as problem-solving, memory, and potentially creative thinking.
As a "low impact" form of exercise, even short bursts of stair climbing can help improve cardiorespiratory fitness and reduce the risk of cardiovascular disease. The improvements in aerobic fitness from climbing stairs at home can even be equivalent to those gained using stair machines at the gym.
It's this everyday simplicity that is stair-climbing's greatest strength. Stairs are everywhere – we encounter them at home, at work and in public. Choosing to take the stairs instead of hopping on an escalator or riding in a lift provides us with an incidental form of exercise that can have an outsized impact on our health.
"It's an exercise that nearly everybody can perform because they have access, and they do it on the daily basis," says Alexis Marcotte-Chenard, a postdoctoral research fellow in heart, lung and vascular health at the University of British Columbia in Kelowna, Canada.
Marcotte-Chenard has been researching how to use exercise and nutrition to reduce the risk of cardiovascular disease, including the effects of "exercise snacks" – brief, spaced-out periods of vigorous activity lasting one minute or less that are performed throughout the day. Stair climbing, he says, is a promising exercise snack as it can be easily adjusted in difficulty by varying pace and requires no complex equipment or cost.
"When you do exercise snacks, you don't need any fancy equipment, you can just use your own body, you can use stairs," says Marcotte-Chenard. "And if you're doing physical activity throughout the day, you don't have to dedicate an hour for your workout."
Research into exercise snacks, also nicknamed "snacktivity," or "VILPA" (vigorous intermittent lifestyle physical activity), is on the rise as researchers search for the best exercise solution to combat sedentary habits and physical inactivity which currently puts approximately 1.8 billion adults worldwide at risk of disease.
But what makes stairs such an effective physical workout?
First, climbing stairs is an easy way to elevate your heart rate – an important part of getting physiological benefits. But there are unique benefits of stair-climbing compared to other forms of exercise.
"It increases your heart rate and your oxygen consumption more than if you do fast walking just because it's harder to go against gravity," says Marcotte-Chenard, "And then, if you talk about the muscle, it's mostly the lower body, and we know that lower body strength is a good indicator of overall health and longevity."
Climbing stairs can increase thigh muscle size and strength, and also requires use of the abdominal muscles for stabilisation going upwards.
You may not even have to sprint up the staircase to get the benefits. Whilst taking two steps at a time can be more difficult, requiring greater work by the muscles around your ankle and knee, the research is split about whether you actually burn more calories going up one step at a time.
And there is another reason to choose the staircase over the stair machine at the gym – going downstairs.
The muscles at the front of your thighs contract in two different ways: when walking upstairs they will shorten, known as concentric contraction, and when walking downstairs they lengthen, known as eccentric contraction. Although concentric contractions require more oxygen, burn more calories during the exercise itself and are considered more difficult, repeating eccentric contractions is more likely to result in bigger and stronger muscle growth. This is because eccentric contractions cause greater muscle damage during exercise and so more calories are burnt long-term during repair and recovery.
The benefits don't end with muscular thighs either. Researchers have found that stair-climbing results in surprising improvements in cognitive ability.
More like this:
Andreas Stenling is an associate professor psychology at Umeå University, Sweden, who primarily researches the longer-term relationships between physical activity and health. He and his colleagues studied the immediate effects of stair-climbing on different cognitive abilities in young adults.
"Inhibition and switching were the two main cognitive functions we focused on here," says Stenling, "Cognitive switching, sometimes called mental flexibility, is how easy we're able to switch between cognitive tasks," he says. "So, going from one task to the other without having to reset your cognition, so to speak. Inhibition is about blocking out irrelevant information while you're engaged in the task." Stenling explains that we know that these cognitive functions are important for learning, cognitive word tasks, abstract thinking, and being able to keep your thoughts on one thing.
Stenling and colleagues found that their stair-climbing exercise significantly improved participants' "switching" abilities, which is also considered the most difficult of the cognitive tasks tested for. They also tested for changes in mood, finding that participants felt happier and more energetic after stair-climbing.
Another study published by researchers at the Yamaguchi University Graduate School of Medicine in Japan also found that people who climbed two flights of stairs displayed more focused problem solving than those who took the elevator. Intriguingly, there weren't any improvements in problem solving when they climbed five or eight flights of stairs, suggesting the effect is not dependent upon the number of stairs. Another study by the same group also found that walking downstairs led to an increase in creative thinking, generating 61% more original ideas than those who travelled using a lift. So if you are looking for a burst of inspiration on a problem you are trying to solve, a quick jaunt up to the next floor and back may be all you need.
There is much interest in the mechanisms which link exercise to cognitive benefits, but little conclusive research. Stenling suggests, however, that the improvements could be linked to the cardiovascular system and the increase in blood flow to the brain, as well as growth hormones such as Brain-Derived Neurotrophic Factor (BDNF), which seem to be impacted quickly by exercise in general.
Researchers including Stenling are also keen to explore whether there may be any delayed effects from stair climbing. Most studies focus on the cognitive effects immediately after climbing some stairs. One recent study found, however, that there were some improvements in memory from stair-climbing that carry over to the next day when paired with good sleep quality.
But while the concept of taking 10,000 steps a day is ingrained in the public mind as the benchmark for daily exercise, is there a similar target we should be aiming for when it comes to stairs?
Before we answer that, it is perhaps worth noting that the 10,000 step count number doesn't have a terribly strong basis in scientific research itself and some studies suggest the benefits tend to plateau after around 7,500 steps. The better known figure actually originates from an advertising campaign coinciding with the 1964 Tokyo Olympics, which took off because the number 10,000 in Japanese (万) resembles a person walking.
The research is similarly sparse when it comes to putting a target on stair climbing. But the studies that do exist suggest that climbing more than five flights of stairs daily (equivalent to 50 steps) is associated with a lower risk of atherosclerotic cardiovascular disease (ASCVD), which is the build-up of plaque in the arteries.
Marcotte-Chenard and his colleagues are optimistic that exercise snacks, specifically stair-climbing, could provide a good solution to breaking sedimentary habits at work. In a study assessing the psychological responses of office employees undertaking stair-climbing in the workplace, Marcotte-Chenard and colleagues found that 71% of employees preferred several small exercise snacks, climbing 60 steps in three different sessions, over one intense HIIT (high intensity interval training) session of climbing 60 steps three times in one session.
"For them [the participants], it's easier to just go one time up and down the stairs and go back to sitting," says Marcotte-Chenard. "And because you spread it out throughout the day, it seems that people enjoy it a little bit more than if they do it in one single session." The researchers' study is unique for being conducted outside the laboratory, which could suggest that the research is more applicable to the real world.
Not all research agrees that home stair-climbing is the answer, with some suggesting it is insufficient physical activity to lower the risk of CVD mortality and premature death. Additionally, sufferers of knee osteoarthritis can find stairs to be a painful ordeal. And observational studies even find that some demographics, such as females and overweight individuals, are less likely to take the stairs where there is an alternative.
But for those able to tackle a staircase, choosing it over a lift or elevator could be a great way of getting some incidental exercise that will benefit both your body and mind. See you at the top.
--
For trusted insights into better health and wellbeing rooted in science, sign up to the Health Fix newsletter, while The Essential List delivers a handpicked selection of features and insights.
For more science, technology, environment and health stories from the BBC, follow us on Facebook, X and Instagram.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Viking's weight-loss pill data disappoints, shares sink
Viking's weight-loss pill data disappoints, shares sink

Reuters

time26 minutes ago

  • Reuters

Viking's weight-loss pill data disappoints, shares sink

Aug 19 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a mid-stage trial, missing Wall Street's top-end expectations of 15% and sending its shares plummeting by 41%. In the 280-person study of obese and overweight adults, those who received the highest 120-milligram dose of Viking's drug, VK2735, shed 12.2% of their body weight on average over 13 weeks versus 10.9% for those who received a placebo. However, about 20% of patients on VK2735 dropped out of the study due to adverse effects, primarily gastrointestinal issues such as vomiting and nausea, compared to 13% in the placebo group. The company will consider increasing it every four weeks for future studies, rather than every two weeks, to help control the side effects, Viking CEO Brian Lian said. Oral weight-loss drugs are expected to widen access for patients averse to injections, helping their makers tap into a projected $150 billion market currently dominated by Novo Nordisk's ( opens new tab Wegovy and Eli Lilly's (LLY.N), opens new tab Zepbound. But so far, oral pills have failed to outperform the injectables in the tight race for these medicines. Analysts expected Viking's drug to help lower body weight by 10% to 15%, following an 8.2% average reduction in an early-stage trial. J.P. Morgan analyst Hardik Parikh said the drug's profile did not measure up to earlier trials, but said side effects might be manageable with dose adjustments, particularly given the high discontinuation rate in the placebo group. Shares of Viking had gained 4.6% this year till Monday's close due to optimism over the obesity pill. In early August, Lilly's experimental daily pill, orforglipron, showed a 12.4% weight loss in a late-stage study over 72 weeks. The news wiped off more than $100 billion from the company's market value on the day. Separately, Novo's oral semaglutide has shown a weight-loss of 15% over 68 weeks. Both drugmakers expect to launch their oral drugs by next year.

US FDA declines to approve PTC Therapeutics' oral drug for rare genetic disorder
US FDA declines to approve PTC Therapeutics' oral drug for rare genetic disorder

Reuters

time26 minutes ago

  • Reuters

US FDA declines to approve PTC Therapeutics' oral drug for rare genetic disorder

Aug 19 (Reuters) - The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' (PTCT.O), opens new tab oral medication for a rare genetic disorder with limited treatment options, the company said on Tuesday. In its so-called Complete Response Letter, the FDA said the data did not provide substantial efficacy evidence for the drug, vatiquinone, in treating Friedreich's ataxia and that a separate study was needed before resubmitting the application. At least three analysts said the regulator's rejection was not surprising and that expectations had been low heading into the decision. PTC's shares reversed premarket losses to rise more than 8% in morning trading. The FDA approved Sephience - PTC's oral therapy for a rare metabolic disorder called phenylketonuria - last month, potentially countering revenue declines due to regulatory scrutiny and competition from cheaper rivals for its top-selling muscular disorder therapies, Translarna and Emflaza. "We see today's CRL as a clearing event since investors can now turn their focus to the Sephience launch," analysts said in a client note. The company said it planned to meet with FDA officials to discuss potential next steps. "We are of course disappointed by the FDA's decision to not approve vatiquinone," CEO Matthew Klein said, adding that the data till date demonstrated that the drug could be safe and effective for children and adults living with the disorder. Friedreich's ataxia is a rare genetic disorder that causes progressive damage to the nervous system, often leading to difficulty in walking, speech problems and heart complications. The disease tends to develop in children and teenagers and gradually worsens over time. Vatiquinonedid not meet its main goal, opens new tab of significantly reducing disease progression in a key late-stage trial that was part of the company's marketing application. Currently, Biogen's (BIIB.O), opens new tab Skyclarys remains the only FDA-approved treatment for Friedreich's ataxia.

Action needed on plastic additives linked to sperm decline, experts warn
Action needed on plastic additives linked to sperm decline, experts warn

The Guardian

time40 minutes ago

  • The Guardian

Action needed on plastic additives linked to sperm decline, experts warn

Action must be taken to curb the use of plastic additives linked to plummeting sperm counts, a leading reproductive scientist has warned, as splits over chemical regulation contributed to the collapse of a crucial treaty on plastic pollution. Across the world, sperm counts have been declining at a rate of about 1% a year for the past 50 years, and human fertility has been diminishing at a similar rate, studies have shown. Increasing levels of obesity, sedentary lifestyles and ageing populations have all been held up as possible causes. But according to Dr Shanna Swan, professor of environmental medicine and public health at the Icahn School of Medicine at Mount Sinai in New York City, environmental factors play the most significant role. Swan said the decline was 'largely, but not entirely due to toxins in the environment that have the ability to interfere with steroid hormones'. In 2017, Swan and her colleagues published a meta-analysis showing a decline in sperm counts of almost 60% among men in North America, Europe and Australia between 1973 and 2011. In 2023, they repeated the research, extending the study to 2018 and including previously unavailable data from Africa, Asia and South America, and made even more shocking findings. 'We separated the countries into western and non-western for analytic purposes, and in both we found a significant decline,' Swan said. 'And the other thing that we found, which was at least as alarming, was that if you looked at all of the studies going back to 1973 you see a 1% per year decline. But if you look at studies published after 2000, you see an over 2% decline. 'So the rate of decline had increased, and had increased significantly in recent years.' Swan's warning comes amid rising alarm at the impact of chemical toxicity on human and environmental health. Two weeks ago, a report published by Deep Science Ventures, a business focused on environmental solutions, which was reviewed by Swan, warned that chemical pollution was 'a threat … of a similar order as climate change', but received far less attention. The decline in sperm rates since about 1950 stands in an inverse relationship to the explosion in the use of plastics. Swan points out that there are now well-established links between common additives to plastics and falling sperm counts. 'Phthalates are chemicals that are put into plastic to give it flexibility and make it soft and flexible,' Swan said. 'So anytime you pick up a soft water bottle or tubing, like medical tubing, or a food container that's soft, you're going to be touching phthalates. 'Then, on the other side, the evil twin of phthalates are the bisphenols. While phthalates make plastic soft and flexible, bisphenols make it hard and inflexible. And phthalates lower testosterone and the bisphenols increase oestrogen.' The effects of these and other endocrine-disrupting chemicals were particularly profound on foetuses and embryos developing in the womb, Swan said. She had previously carried out research into the effects of phthalates on unborn male babies, finding that exposure at a critical point in gestation could lead to subtle deformities in sexual development. Sign up to Down to Earth The planet's most important stories. Get all the week's environment news - the good, the bad and the essential after newsletter promotion The adverse effects of phthalates in the womb, known as 'phthalate syndrome', included smaller penises, a shorter distance between the genitals and anus, and – once children reached sexual maturity – lowered sperm counts, Swan said. 'We showed the link between the exposure and fertility,' she said. 'And when you see that total sperm count going down worldwide, what I believe is you're seeing an important effect of early exposure to these chemicals.' Swan would not be drawn into commenting on the talks, which were under way as she spoke, in Geneva for a comprehensive treaty to end the plastic pollution crisis. But she said action needed to be taken on the use of plastic additives, with an urgent need for safer replacements. 'In the meantime, yes people can be careful,' she said. 'They can reuse materials. They should try to look at what they use in their takeout containers and carry little glass bottles around to get their drinks. It's very important. But it's not solving a bigger problem, which is how do we make these things that we have become dependent on in a safer way?' Signs of a solution are not promising. Last week, after nearly two weeks of talks, negotiators left Geneva on Friday having failed to reach an agreement, after oil- and gas-producing nations objected to calls for limits to production and curbs on chemicals. Almost 100 nations had signed a declaration calling for a 'legally binding obligation to phase out those most harmful plastic products and chemicals of concern'. But both texts drafted by Luis Vayas Valdivieso, the chair of the negotiating committee, omitted any reference to controls on chemicals.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store